102 related articles for article (PubMed ID: 23159401)
21. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers.
Ruff SM; Cloyd JM; Pawlik TM
Ann Surg Oncol; 2023 Dec; 30(13):7935-7949. PubMed ID: 37691030
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
[TBL] [Abstract][Full Text] [Related]
23. Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.
Cerrito L; Ainora ME; Borriello R; Piccirilli G; Garcovich M; Riccardi L; Pompili M; Gasbarrini A; Zocco MA
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444503
[TBL] [Abstract][Full Text] [Related]
24. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.
Kubo S; Shinkawa H; Asaoka Y; Ioka T; Igaki H; Izumi N; Itoi T; Unno M; Ohtsuka M; Okusaka T; Kadoya M; Kudo M; Kumada T; Kokudo N; Sakamoto M; Sakamoto Y; Sakurai H; Takayama T; Nakashima O; Nagata Y; Hatano E; Harada K; Murakami T; Yamamoto M
Liver Cancer; 2022 Jul; 11(4):290-314. PubMed ID: 35978598
[TBL] [Abstract][Full Text] [Related]
25. A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.
De Muzio F; Grassi F; Dell'Aversana F; Fusco R; Danti G; Flammia F; Chiti G; Valeri T; Agostini A; Palumbo P; Bruno F; Cutolo C; Grassi R; Simonetti I; Giovagnoni A; Miele V; Barile A; Granata V
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885561
[TBL] [Abstract][Full Text] [Related]
26. Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.
Zhao F; Pang G; Li X; Yang S; Zhong H
Sci Rep; 2021 Nov; 11(1):23163. PubMed ID: 34848818
[TBL] [Abstract][Full Text] [Related]
27. Clinical Staging of Mass-Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging.
Kim YY; Yeom SK; Shin H; Choi SH; Rhee H; Park JH; Cho ES; Park S; Lee SS; Park MS
Hepatol Commun; 2021 Dec; 5(12):2009-2018. PubMed ID: 34559470
[TBL] [Abstract][Full Text] [Related]
28. Inter-observer agreement of computed tomography and magnetic resonance imaging on gross tumor volume delineation of intrahepatic cholangiocarcinoma: an initial study.
Zhou N; Hu A; Shi Z; Wang X; Zhu Q; Zhou Q; Ma J; Zhao F; Kong W; He J
Quant Imaging Med Surg; 2021 Feb; 11(2):579-585. PubMed ID: 33532258
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review.
Yang Y; Liu C; Qi L; Zhao T; Feng Y; Ai X; Zhao X; Li J; Zhu Q
Dig Dis Sci; 2020 Sep; 65(9):2492-2502. PubMed ID: 31808004
[TBL] [Abstract][Full Text] [Related]
30. Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma.
Jiang H; Liu X; Chen J; Wei Y; Lee JM; Cao L; Wu Y; Duan T; Li X; Ma L; Song B
Cancer Imaging; 2019 Dec; 19(1):84. PubMed ID: 31806050
[TBL] [Abstract][Full Text] [Related]
31. Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
Fraum TJ; Cannella R; Ludwig DR; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
Eur Radiol; 2020 Feb; 30(2):996-1007. PubMed ID: 31654212
[TBL] [Abstract][Full Text] [Related]
32. Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Rahnemai-Azar AA; Pandey P; Kamel I; Pawlik TM
Hepat Oncol; 2016 Oct; 3(4):223-239. PubMed ID: 30191045
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging.
Wei Y; Gao F; Zheng D; Huang Z; Wang M; Hu F; Chen C; Duan T; Chen J; Cao L; Song B
Oncotarget; 2018 Jan; 9(8):7975-7983. PubMed ID: 29487707
[TBL] [Abstract][Full Text] [Related]
34. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
[TBL] [Abstract][Full Text] [Related]
35. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.
Sheybani A; Gaba RC; Lokken RP; Berggruen SM; Mar WA
Curr Gastroenterol Rep; 2017 Oct; 19(11):58. PubMed ID: 29044439
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.
Korean Society of Abdominal Radiology
Korean J Radiol; 2017; 18(3):427-443. PubMed ID: 28458595
[TBL] [Abstract][Full Text] [Related]
37. Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC).
Cieszanowski A; Podgórska J; Rosiak G; Maj E; Grudziński IP; Kaczyński B; Szeszkowski W; Milczarek K; Rowiński O
Pol J Radiol; 2016; 81():103-9. PubMed ID: 27026795
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI.
Joo I; Lee JM
Liver Cancer; 2016 Feb; 5(1):67-87. PubMed ID: 26989660
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
Park YS; Lee CH; Kim JW; Shin S; Park CM
World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
